HCA DCF model pegs intrinsic value at $740
Alpha Vantage · GuruFocus · · AI-summarised by FinFlash
A discounted cash flow analysis of HCA Healthcare Inc (HCA) puts intrinsic value at $740.05 against a current price of $434.92, suggesting the shares are undervalued. Both earnings-based and free cash flow-based DCF models, along with the GF Value, point to undervaluation, while the GF Score reflects strong fundamentals despite a low predictability rank. Analysts carry an average target of $454.23, implying 4.4% upside, with 14 buy, 10 hold and 1 sell rating.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.